Ara
Toplam kayıt 5, listelenen: 1-5
BreCaHAD: A dataset for breast cancer histopathological annotation and diagnosis
(BioMed Central Ltd., 2019)
Objectives: Histopathological tissue analysis by a pathologist determines the diagnosis and prognosis of most tumors, such as breast cancer. To estimate the aggressiveness of cancer, a pathologist evaluates the microscopic ...
An examination of health care utilization during the COVID-19 pandemic among women with early-stage hormone receptor-positive breast cancer
(BioMed Central Ltd, 2022)
Background: Women undergoing treatment for breast cancer require frequent clinic visits for maintenance of therapy. With COVID-19 causing health care disruptions, it is important to learn about how this population’s access ...
Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy (vol 23, 136, 2023)
(BMC, 2023)
Following publication of the original article [1], the authors reported an error in the author name of Enes Erul.
Effects of chitosan nanoparticles with long synthetic siRNAs targeting VEGF in triple-negative breast cancer cells
(Faculdade de Ciencias Farmaceuticas (Biblioteca), 2023)
Vascular endothelial growth factor (VEGF) is an essential angiogenic factor in breast cancer development and metastasis. Small interfering RNAs (siRNAs) can specifically silence genes via the RNA interference pathway, ...
The correlation between progesterone and mammographic density in postmenopausal women: A systematic review of the literature and meta-analysis
(Cureus Inc, 2023)
Higher mammographic breast density in premenopausal and postmenopausal women is related to a higher breast cancer risk. In this review, we analyze the correlation between estrogen, progesterone, and mammographic density ...